Jagsonpal Pharmaceuticals Limited (BOM:507789)
202.75
+0.30 (0.15%)
At close: Jun 5, 2026
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 13.63 billion as of June 5, 2026. Its market cap has decreased by -6.49% in one year.
Market Cap
13.63B
Enterprise Value
12.65B
Revenue
2.87B
Ranking
n/a
PE Ratio
31.64
Stock Price
202.75
Market Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 13.63B, a decrease of -22.68%. That is a compound annual growth rate of -0.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 13.66B | 6.19% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suven Life Sciences | 72.56B |
| Gujarat Themis Biosyn | 43.78B |
| IOL Chemicals and Pharmaceuticals | 38.45B |
| Sai Parenteral's | 22.07B |
| NGL Fine-Chem | 16.35B |
| Bajaj HealthCare | 10.05B |
| Shree Ganesh Remedies | 8.37B |
| Anlon Healthcare | 7.29B |